Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier

Cytotechnology

Volumn 62, Issue 6, 2010, Pages 519-529

  Bachmeier, Corbin ^a   Mullan, Michael ^a   Paris, Daniel ^a  

^a ROSKAMP INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; Blood brain barrier; LRP1; RAGE

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CARRIER PROTEIN; CELL MARKER; FLUORESCEIN;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL ISOLATION; CELL LINE; CELL MEMBRANE PERMEABILITY; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUOROMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN TRANSPORT; TRANSCYTOSIS;

EID: 78651497015     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-010-9313-x     Document Type: Article

References (28)

1. P Artursson 1990 Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J Pharm Sci 79 476 482 1:CAS:528:DyaK3cXkvFSru74%3D 10.1002/jps.2600790604
2. GL Bowman JA Kaye M Moore D Waichunas NE Carlson JF Quinn 2007 Blood-brain barrier impairment in Alzheimer disease: stability and functional significance Neurology 68 1809 1814 1:STN:280:DC%2BD2szgsVyntQ%3D%3D 10.1212/01.wnl.0000262031.18018.1a
3. R Deane Z Wu BV Zlokovic 2004 RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier Stroke 35 2628 2631 1:CAS:528:DC%2BD2cXovVCgtLY%3D 10.1161/01.STR.0000143452.85382.d1
4. MA Deli CS Abraham Y Kataoka M Niwa 2005 Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology Cell Mol Neurobiol 25 59 127 10.1007/s10571-004-1377-8
5. PE Eddy BE Maleef TK Hart PL Smith 1997 In vitro models to predict blood-brain barrier permeability Adv Drug Del Rev 23 185 198 1:CAS:528:DyaK2sXhtlKks70%3D 10.1016/S0169-409X(96)00435-8
6. B Engelhardt L Sorokin 2009 The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction Semin Immunopathol 31 497 511 10.1007/s00281-009-0177-0
7. PJ Gaillard AG de Boer 2000 Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug Eur J Pharm Sci 12 95 102 1:CAS:528:DC%2BD3cXotlGjsLs%3D 10.1016/S0928-0987(00)00152-4
8. L Giliberto D Zhou R Weldon E Tamagno P De Luca M Tabaton L D'Adamio 2008 Evidence that the amyloid beta precursor protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role Mol Neurodegener 3 12 10.1186/1750-1326-3-12
9. FJ Gonzalez-Velasquez JA Kotarek MA Moss 2008 Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers J Neurochem 107 466 477 1:CAS:528:DC%2BD1cXhtlajtbrL 10.1111/j.1471-4159.2008.05618.x
10. JL Guerin DJ Bobilya 1997 Hypothalamic extract influences a blood-brain barrier model of porcine brain capillary endothelial cells Neurochem Res 22 321 326 1:CAS:528:DyaK2sXhs1GksL0%3D 10.1023/A:1022499023993
11. M Gumbleton KL Audus 2001 Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier J Pharm Sci 90 1681 1698 1:CAS:528:DC%2BD3MXosVKltrw%3D 10.1002/jps.1119
12. G Jancso F Domoki P Santha J Varga J Fischer K Orosz B Penke A Becskei M Dux L Toth 1998 Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats Neurosci Lett 253 139 141 1:CAS:528:DyaK1cXlsl2ksr4%3D 10.1016/S0304-3940(98)00622-3
13. FM LaFerla KN Green S Oddo 2007 Intracellular amyloid-beta in Alzheimer's disease Nat Rev Neurosci 8 499 509 1:CAS:528:DC%2BD2sXmslWjsr8%3D 10.1038/nrn2168
14. G Li MJ Simon LM Cancel ZD Shi X Ji JM Tarbell B Morrison 3rd BM Fu 2010 Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies Ann Biomed Eng 38 2499 2511 10.1007/s10439-010-0023-5
15. R Liu S Mori H Wake J Zhang K Liu Y Izushi HK Takahashi B Peng M Nishibori 2009 Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts: heparin's effect on binding Acta Med Okayama 63 203 211 1:CAS:528:DC%2BD1MXhtFCku7fK
16. LF Lue YM Kuo AE Roher L Brachova Y Shen L Sue T Beach JH Kurth RE Rydel J Rogers 1999 Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am J Pathol 155 853 862 1:STN:280:DyaK1MvhvFarsA%3D%3D
17. SH Ma LA Lepak RJ Hussain W Shain ML Shuler 2005 An endothelial and astrocyte co-culture model of the blood-brain barrier utilizing an ultra-thin, nanofabricated silicon nitride membrane Lab Chip 5 74 85 1:CAS:528: DC%2BD2cXhtFansLzI 10.1039/b405713a
18. JB Mackic M Stins JG McComb M Calero J Ghiso KS Kim SD Yan D Stern AM Schmidt B Frangione BV Zlokovic 1998 Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer J Clin Invest 102 734 743 1:CAS:528:DyaK1cXlsFaru7o%3D 10.1172/JCI2029
19. S Marco SD Skaper 2006 Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells Neurosci Lett 401 219 224 1:CAS:528:DC%2BD28XkvVymsb0%3D 10.1016/j.neulet.2006. 03.047
20. PD Mehta 2007 Amyloid beta protein as a marker or risk factor of Alzheimer's disease Curr Alzheimer Res 4 359 363 1:CAS:528:DC%2BD2sXhtlSitL7I 10.2174/156720507781788891
21. E Nagababu PV Usatyuk D Enika V Natarajan JM Rifkind 2009 Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins J Alzheimers Dis 17 845 854 1:CAS:528:DC%2BD1MXptVChtrs%3D
22. B Nazer S Hong DJ Selkoe 2008 LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model Neurobiol Dis 30 94 102 1:CAS:528:DC%2BD1cXjs1Gru7s%3D 10.1016/j.nbd.2007.12.005
23. I Skoog A Wallin P Fredman C Hesse O Aevarsson I Karlsson CG Gottfries K Blennow 1998 A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia Neurology 50 966 971 1:STN:280:DyaK1c3is1Sgsw%3D%3D
24. N Strazielle JF Ghersi-Egea J Ghiso MP Dehouck B Frangione C Patlak J Fenstermacher P Gorevic 2000 In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability J Neuropathol Exp Neurol 59 29 38 1:CAS:528:DC%2BD3cXpvFKlsg%3D%3D
25. T Terasaki K Hosoya 2001 Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions Biol Pharm Bull 24 111 118 1:CAS:528:DC%2BD3MXhtVSitb4%3D 10.1248/bpb.24.111
26. M Ujiie DL Dickstein DA Carlow WA Jefferies 2003 Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model Microcirculation 10 463 470 1:CAS:528:DC%2BD2cXms1agtQ%3D%3D
27. K Yamada T Hashimoto C Yabuki Y Nagae M Tachikawa DK Strickland Q Liu G Bu JM Basak DM Holtzman S Ohtsuki T Terasaki T Iwatsubo 2008 The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells J Biol Chem 283 34554 34562 1:CAS:528:DC%2BD1cXhsVGqtrjP 10.1074/jbc.M801487200
28. BD Zipser CE Johanson L Gonzalez TM Berzin R Tavares CM Hulette MP Vitek V Hovanesian EG Stopa 2007 Microvascular injury and blood-brain barrier leakage in Alzheimer's disease Neurobiol Aging 28 977 986 1:CAS:528:DC%2BD2sXkslegu7k%3D 10.1016/j.neurobiolaging.2006.05.016